http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-1046410-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_234dd467415095b40bb35417bf086570 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4858 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7048 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-555 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-04 |
filingDate | 1975-04-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 1979-01-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ce76f7080b2235275badc0e9ee13616f |
publicationDate | 1979-01-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CA-1046410-A |
titleOfInvention | Cardiotonic composition |
abstract | ABSTRACT OF THE DISCLOSURE A cardiotonic dosage unit form comprises a soft gelatine capsule containing a liquid cardiotonic composition comprising (a) a cardiac glycoside, preferably digitoxin or digoxin; (b) dimethyl formamide or dimethyl acetamide; and (c) a liquid polyethylene glycol and also, optionally, (d) propylene glycol or glycerin. The weight ratio of dimethyl acetamide or dimethyl formamide to cardiac glyceride is from 5:1 to 15:1 and the polyethylene glycol forms at least 75% by weight of the total composition contained in the gelatine capsule. |
priorityDate | 1974-04-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 56.